These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 31510053

  • 21. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.
    Kim YG, Song SB, Lee SH, Moon JY, Jeong KH, Lee TW, Ihm CG.
    Clin Exp Nephrol; 2011 Oct; 15(5):720-726. PubMed ID: 21695414
    [Abstract] [Full Text] [Related]

  • 22. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
    Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera SM, Wyatt RJ, Sýkora J, Sládková E, Hes O, Mischak H, McGuire BM.
    Electrophoresis; 2007 Dec; 28(23):4469-83. PubMed ID: 18004714
    [Abstract] [Full Text] [Related]

  • 23. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
    Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W.
    Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
    [Abstract] [Full Text] [Related]

  • 24. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
    Rauta V, Finne P, Fagerudd J, Rosenlöf K, Törnroth T, Grönhagen-Riska C.
    Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
    [Abstract] [Full Text] [Related]

  • 25. Corticosteroid therapy in IgA nephropathy with minimal proteinuria and high renal pathological score: A single‑center cohort study.
    Tang Y, He H, Sun W, Hu P, Chen X, Xu X.
    Mol Med Rep; 2018 Oct; 18(4):4103-4112. PubMed ID: 30132546
    [Abstract] [Full Text] [Related]

  • 26. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 27. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
    Kalliakmani P, Nakopoulou L, Tsakas S, Gerolymos M, Papasotiriou M, Goumenos DS.
    Clin Nephrol; 2011 Aug 30; 76(2):144-50. PubMed ID: 21762647
    [Abstract] [Full Text] [Related]

  • 28. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 29. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
    Guan J, Wang M, Zhao M, Ni W, Zhang M.
    BMC Nephrol; 2023 Mar 20; 24(1):60. PubMed ID: 36941570
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
    Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y.
    Clin Exp Nephrol; 2020 Oct 20; 24(10):927-934. PubMed ID: 32642919
    [Abstract] [Full Text] [Related]

  • 31. Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria.
    Xu PC, Wei L, Shang WY, Tian SL, Gu DM, Yan TK, Lin S.
    BMC Nephrol; 2014 Jul 07; 15():107. PubMed ID: 24998891
    [Abstract] [Full Text] [Related]

  • 32. Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial.
    Jo YI, Na HY, Moon JY, Han SW, Yang DH, Lee SH, Park HC, Choi HY, Lim SD, Kie JH, Lee YK, Shin SK.
    Korean J Intern Med; 2016 Mar 07; 31(2):335-43. PubMed ID: 26874511
    [Abstract] [Full Text] [Related]

  • 33. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.
    Cao Y, Wang Y, Liu Y, Zhu X, Zhang G, Wang S, Chen X, Liu D, Fu C.
    Dis Markers; 2019 Mar 07; 2019():2424751. PubMed ID: 31485275
    [Abstract] [Full Text] [Related]

  • 34. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.
    Guo Z, Wang Z, Lu C, Yang S, Sun H, Reziw, Guo Y, Sun W, Yue H.
    BMC Nephrol; 2018 Dec 14; 19(1):358. PubMed ID: 30547763
    [Abstract] [Full Text] [Related]

  • 35. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH.
    Nephrol Dial Transplant; 2011 Oct 14; 26(10):3229-36. PubMed ID: 21402675
    [Abstract] [Full Text] [Related]

  • 36. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R.
    Proteomics; 2013 Jan 14; 13(1):142-52. PubMed ID: 23161552
    [Abstract] [Full Text] [Related]

  • 37. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S, Khramova A, Saeed A, Guron G, Boi R, Mölne J, Ebefors K, Nyström J.
    BMC Nephrol; 2023 Jun 07; 24(1):160. PubMed ID: 37286948
    [Abstract] [Full Text] [Related]

  • 38. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, Zhang P, Kuang Q, Wang R, Wang M.
    J Nephrol; 2020 Dec 07; 33(6):1263-1273. PubMed ID: 32507961
    [Abstract] [Full Text] [Related]

  • 39. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy.
    Seo MS, Park MY, Choi SJ, Jeon JS, Noh H, Kim JK, Han DC, Hwang SD, Jin SY, Kwon SH.
    BMC Nephrol; 2013 Jul 09; 14():139. PubMed ID: 23837450
    [Abstract] [Full Text] [Related]

  • 40. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    Bagchi S, Lingaiah R, Mani K, Barwad A, Singh G, Balooni V, Bhowmik D, Agarwal SK.
    PLoS One; 2019 Jul 09; 14(3):e0214256. PubMed ID: 30917188
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.